Table:
begin	end	state
1	27	cytoplasmic
28	49	transmembrane
50	54	non-cytoplasmic
55	72	transmembrane
73	77	cytoplasmic
78	97	transmembrane
98	102	non-cytoplasmic
103	123	transmembrane
124	131	cytoplasmic
132	153	transmembrane
154	175	non-cytoplasmic
176	200	transmembrane
201	210	cytoplasmic
211	234	transmembrane
235	252	non-cytoplasmic
253	276	transmembrane
277	323	cytoplasmic
324	345	transmembrane
346	348	non-cytoplasmic
349	370	transmembrane
371	386	cytoplasmic
387	416	transmembrane
417	452	non-cytoplasmic
453	522	cytoplasmic

Input:
>Pf6N2E2_4131
MAIPTRHSLFPFLSWLPRQTRASVGRDLVVGLSGAILALPQSIAYALIAGLPPEYGLYAA
IVPVLIACLWGSSWHLICGPTAAISIVLYATVSPLAVPASQDYITLILLLTVLAGIFQWL
LGLLRFGALVNFVSHSVVLGFTLGAAVVIALGQLPNLLGLDLPNEATALRGLLMLVSHIG
AVDKPSLLLGLGTLVLGVVLKRLLPRWPSLLITLVISSLVVWLWPAMFGHVALVSAFAGR
LPPFTPLPLDLELILRLLPGAVAVGMLGLVTSLSIARSLSVRSGQLLDANQEVRAQGLSN
IVGGFFSGSLSAGSFTRSGLSYEAGACSPLAGVFSALWVALFAVAGANLIAHIPIPAMAG
SILLIAWGLVDHRGIRALYRVSRAEFVVMGLTCLATLLLELQTAIYAGVLASLFFYLKRT
SQPRVQHFREGEAEILRVGGSIFFGASHYLQARLQRLQAQRVVIDAQQINFIDYSGVEML
HQEARRLRSQGRSLTLRMARPQVVEELLKLEGAEHCPILFED

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server